← Open Payments lookup

GEORGE DIGGS: Open Payments

NPI 1699700880 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,087 in 118 payments from 13 companies in 2025. Trend: 2023 $1,752 · 2024 $1,609 · 2025 $2,087

Food & beverage: $1,976Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$420
Neurocrine BioSciences, Inc.16$408
Alkermes, Inc.18$331
Otsuka America Pharmaceutical, Inc.13$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$167
Vanda Pharmaceuticals Inc.7$163
E.R. Squibb & Sons, L.L.C.11$158
Janssen Pharmaceuticals, Inc4$71
ABBVIE INC.3$60
Braeburn Inc.2$42

Products named: INGREZZA, ARISTADA, UZEDY, REXULTI, CAPLYTA, FANAPT, COBENFY, LYBALVI.

Industry payments across LA — which companies pay providers there.